These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27309063)

  • 1. Added Value of Avian Influenza (H5) Day-Old Chick Vaccination for Disease Control in Egypt.
    Peyre M; Choisy M; Sobhy H; Kilany WH; Gély M; Tripodi A; Dauphin G; Saad M; Roger F; Lubroth J; Jobre Y
    Avian Dis; 2016 May; 60(1 Suppl):245-52. PubMed ID: 27309063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effectiveness of rHVT-H5, inactivated H5 and rHVT-H5 with inactivated H5 prime/boost vaccination regimes in commercial broiler chickens carrying MDAs against HPAI H5N1 clade 2.2.1 virus.
    Kilany WH; Hassan MK; Safwat M; Mohammed S; Selim A; VonDobschuetz S; Dauphin G; Lubroth J; Jobre Y
    Avian Pathol; 2015 Oct; 44(5):333-41. PubMed ID: 26023824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
    Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
    PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate.
    Grund C; Abdelwhab el-SM; Arafa AS; Ziller M; Hassan MK; Aly MM; Hafez HM; Harder TC; Beer M
    Vaccine; 2011 Jul; 29(33):5567-73. PubMed ID: 21244859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection conferred by recombinant turkey herpesvirus avian influenza (rHVT-H5) vaccine in the rearing period in two commercial layer chicken breeds in Egypt.
    Kilany W; Dauphin G; Selim A; Tripodi A; Samy M; Sobhy H; VonDobschuetz S; Safwat M; Saad M; Erfan A; Hassan M; Lubroth J; Jobre Y
    Avian Pathol; 2014; 43(6):514-23. PubMed ID: 25245772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
    Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
    Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental and Field Results Regarding Immunity Induced by a Recombinant Turkey Herpesvirus H5 Vector Vaccine Against H5N1 and Other H5 Highly Pathogenic Avian Influenza Virus Challenges.
    Gardin Y; Palya V; Dorsey KM; El-Attrache J; Bonfante F; Wit Sd; Kapczynski D; Kilany WH; Rauw F; Steensels M; Soejoedono RD
    Avian Dis; 2016 May; 60(1 Suppl):232-7. PubMed ID: 27309060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination.
    Swayne DE; Pavade G; Hamilton K; Vallat B; Miyagishima K
    Rev Sci Tech; 2011 Dec; 30(3):839-70. PubMed ID: 22435196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of gallinaceous poultry for H5N1 highly pathogenic avian influenza: current questions and new technology.
    Spackman E; Swayne DE
    Virus Res; 2013 Dec; 178(1):121-32. PubMed ID: 23524326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stronger Interference of Avian Influenza Virus-Specific Than Newcastle Disease Virus-Specific Maternally Derived Antibodies with a Recombinant NDV-H5 Vaccine.
    Lardinois A; Vandersleyen O; Steensels M; Desloges N; Mast J; van den Berg T; Lambrecht B
    Avian Dis; 2016 May; 60(1 Suppl):191-201. PubMed ID: 27309055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine Protection of Turkeys Against H5N1 Highly Pathogenic Avian Influenza Virus with a Recombinant Turkey Herpesvirus Expressing the Hemagglutinin Gene of Avian Influenza.
    Kapczynski DR; Dorsey K; Chrzastek K; Moraes M; Jackwood M; Hilt D; Gardin Y
    Avian Dis; 2016 Jun; 60(2):413-7. PubMed ID: 27309280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
    Connie Leung YH; Luk G; Sia SF; Wu YO; Ho CK; Chow KC; Tang SC; Guan Y; Malik Peiris JS
    Vaccine; 2013 Aug; 31(35):3536-42. PubMed ID: 23791547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterologous post-infection immunity against Egyptian avian influenza virus (AIV) H9N2 modulates the course of subsequent infection by highly pathogenic AIV H5N1, but vaccination immunity does not.
    Naguib MM; Grund C; Arafa AS; Abdelwhab EM; Beer M; Harder TC
    J Gen Virol; 2017 Jun; 98(6):1169-1173. PubMed ID: 28590242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens.
    Pushko P; Tretyakova I; Hidajat R; Zsak A; Chrzastek K; Tumpey TM; Kapczynski DR
    Virology; 2017 Jan; 501():176-182. PubMed ID: 27936463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avian influenza A (H5N1) outbreaks in different poultry farm types in Egypt: the effect of vaccination, closing status and farm size.
    Artois J; Ippoliti C; Conte A; Dhingra MS; Alfonso P; Tahawy AE; Elbestawy A; Ellakany HF; Gilbert M
    BMC Vet Res; 2018 Jun; 14(1):187. PubMed ID: 29914481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling influenza A H5N1 vaccination strategy scenarios in the household poultry sector in Egypt.
    El Masry I; Rijks J; Peyre M; Taylor N; Lubroth J; Jobre Y
    Trop Anim Health Prod; 2014 Jan; 46(1):57-63. PubMed ID: 23868547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
    Kandeil A; Moatasim Y; Gomaa MR; Shehata MM; El-Shesheny R; Barakat A; Webby RJ; Ali MA; Kayali G
    Vaccine; 2016 Jan; 34(2):218-224. PubMed ID: 26620838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adjuvant effect of Sophy β-glucan to the antibody response in poultry immunized by the avian influenza A H5N1 and H5N2 vaccines.
    Le T; Le T; Doan TH; Quyen D; Le KX; Pham V; Nagataki M; Nomura H; Ikeue Y; Watanabe Y; Agatsuma T
    J Microbiol Biotechnol; 2011 Apr; 21(4):405-11. PubMed ID: 21532325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an effective contemporary trivalent avian influenza vaccine against circulating H5N1, H5N8, and H9N2 in Egypt.
    Gomaa MR; Khalil AA; Kandeil A; Sabir JSM; Kayed A; Moatasim Y; El Saied MF; El-Safty MM; Kayali G; Ali MA
    Poult Sci; 2019 Dec; 98(12):6289-6295. PubMed ID: 31265106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1.
    Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
    Vet Microbiol; 2012 Feb; 155(1):13-20. PubMed ID: 21920677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.